Evidence map›Paper›PMID 39422740›Full record

ArticleEnvironmental science & technology2024

Multiple-Criteria Decision Analysis for Assessments of Chemical Alternatives (MCDA-ACA).

Rachel L London, Juliane Glüge, Martin Scheringer

Abstract read
In one paragraph

Article in Environmental science & technology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. The PFAS roadmap-Navigating a path together to improved management.Sustainability science and technology · 2026
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rachel L LondonInstitute of Biogeochemistry and Pollutant Dynamics, ETH Zürich, 8092 Zürich, Switzerland.
Juliane GlügeInstitute of Biogeochemistry and Pollutant Dynamics, ETH Zürich, 8092 Zürich, Switzerland.ORCID 0000-0003-1997-2750
Martin ScheringerInstitute of Biogeochemistry and Pollutant Dynamics, ETH Zürich, 8092 Zürich, Switzerland.ORCID 0000-0002-0809-7826

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A comprehensive assessment of chemical alternatives (ACA) is necessary to avoid regrettable substitution. In a preceding study, an analysis of six hazard assessment methods found that none of them are fully aligned with the hazard assessment criteria of Article 57 of the European REACH regulation, indicating a need for a method better reflecting hazard assessment schemes in European chemical regulations. This paper presents a multiple-criteria decision analysis (MCDA) method for the ACA that takes the criteria of Article 57 of REACH into account. Investigated and presented are objective hierarchies, the aggregation of objectives, the curvature of the value functions, weights, and the introduction of a classification threshold. The MCDA-ACA method allows for the aggregation of hazards in such a way that poor performance in one hazard cannot be compensated for by good performance in another hazard. The method parameters were developed and tested using two data sets with the aim to classify chemical alternatives into acceptable (nonregrettable) and unacceptable (regrettable) alternatives according to the regulations set in Europe. The flexibility of the general method was explored by adapting the method to align with two hazard assessment schemes, Article 57 of REACH and GreenScreen. The results show that MCDA-ACA is so flexible and transparent that it can easily be adapted to various hazard assessment schemes.

Indexed as

Decision Support TechniquesEuropeHazardous SubstancesRisk AssessmentHazardous Substancesassessment of alternativeschemical hazard assessmentminimum aggregationmultiple-criteria decision analysisregrettable substitutionsubstance of very high concern (SVHC)

Identifiers

PMID39422740
PMCPMC11526351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.